{"id":5182,"date":"2021-09-24T19:03:00","date_gmt":"2021-09-24T16:03:00","guid":{"rendered":"https:\/\/test1.xsights.co.uk\/?p=5182"},"modified":"2023-04-18T12:26:38","modified_gmt":"2023-04-18T09:26:38","slug":"molekuler-diyagnostik-pazari","status":"publish","type":"post","link":"https:\/\/www.xsights.co.uk\/tr\/molekuler-diyagnostik-pazari\/","title":{"rendered":"Molek\u00fcler Diyagnostik Pazar\u0131"},"content":{"rendered":"\n

Molek\u00fcler Diyagnostik Pazar\u0131 raporuna eri\u015fmek i\u00e7in t\u0131klay\u0131n\u0131z. <\/a><\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

\u0130\u00e7indekiler<\/h3>\n\n\n\n

1. Y\u00d6NET\u0130C\u0130 \u00d6ZET\u0130  
2. AMA\u00c7 ve Y\u00d6NTEM  
3. G\u0130R\u0130\u015e  
3.1. Molek\u00fcler Diyagnostik ve Kullan\u0131m Alanlar\u0131  
4. GLOBAL MOLEK\u00dcLER D\u0130YAGNOST\u0130K PAZARI  
4.1. Pazara Genel Bak\u0131\u015f  
4.2. \u00dcr\u00fcn Tiplerine G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve Tahminleri  
4.2.1. Kit Pazar\u0131  
4.2.2. Sarf Malzemeleri Pazar\u0131  
4.2.3. Cihaz Pazar\u0131  
4.2.4. Yaz\u0131l\u0131m Pazar\u0131  
4.3. Kullan\u0131m Amac\u0131na G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve Tahminleri  
4.4. Teknolojiye G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve Tahminleri  
4.4.1. Polimeraz Zincir Reaksiyonu (Polymerase Chain Reaction, PCR)  
4.4.1.1. PCR T\u00fcrleri  
4.4.2. Floresan In Situ Melezleme  
4.4.3. DNA Dizileme  
4.4.4. DNA Mikro\u00e7ipleri  
4.4.5. \u0130zotermal N\u00fckleik Asit Amplifikasyonu  
4.4.6. Transkripsiyon Arac\u0131l\u0131 Amplifikasyon (TMA)  
4.4.7. Di\u011ferler Teknolojiler  
4.5. B\u00f6lgeler ve \u00dclkeler Baz\u0131nda Molek\u00fcler Diyagnostik Cihaz ve Ekipmanlar Pazar Analizi  
4.5.1. Asya-Pasifik B\u00f6lgesi Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131  
4.5.1.1. Asya-Pasifik Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131-\u00dclke Analizleri  
4.5.2. Bat\u0131 Avrupa Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131  
4.5.2.1. Bat\u0131 Avrupa Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131-\u00dclke Analizleri 
4.5.3. Do\u011fu Avrupa Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131 
4.5.3.1. Do\u011fu Avrupa Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131-\u00dclke Analizleri 
4.5.4. G\u00fcney Amerika Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131 
4.5.4.1. G\u00fcney Amerika Molek\u00fcler Diyagnostik Cihaz ve Ekipman Pazar\u0131-\u00dclke Analizleri 
4.6. Sekt\u00f6rdeki B\u00fcy\u00fck Oyuncular 
4.6.1. Ro F. Hoffmann-La Roche Ltd 
4.6.2. Abbott Laboratories 
4.6.3. QIAGEN 
4.6.4. Biom\u00e9rieux 
4.6.5. Danaher Corporation 
4.6.6. Seegene 
4.6.7. Becton Dickinson& Co. 
4.6.8. Siemens Healthineers AG 
5. T\u00dcRK\u0130YE MOLEK\u00dcLER D\u0130YAGNOST\u0130K PAZARI 
5.1. Pazara Genel Bak\u0131\u015f 
5.2. Anatolia Geneworks 
5.2.1. PCR \u0130zolasyon Kitleri T\u00fcrkiye \u0130thalat 
5.2.2. PCR \u0130zolasyon Kitleri T\u00fcrkiye \u0130hracat 
5.2.3. PCR Cihazlar\u0131 T\u00fcrkiye \u0130thalat 
5.2.4. PCR Cihazlar\u0131 T\u00fcrkiye \u0130hracat 
5.2.5. \u0130zolasyon Cihazlar\u0131 T\u00fcrkiye \u0130thalat 
5.2.6. \u0130zolasyon Cihazlar\u0131 T\u00fcrkiye \u0130hracat 
5.2.7. Aparatlar T\u00fcrkiye \u0130thalat 
5.2.8. Aparatlar T\u00fcrkiye \u0130hracat 
5.3. T\u00fcrkiye G\u0131da G\u00fcvenli\u011fi Pazar\u0131 
5.4. T\u00fcrkiye G\u0131da G\u00fcvenli\u011fi GDO Tespiti ve \u0130\u015flenmi\u015f G\u0131dalarda T\u00fcr Tayini Pazar\u0131 
6. SONU\u00c7 ve \u00d6NER\u0130LER 
6.1. Pazar Trendi Odakl\u0131 Stratejiler <\/p>\n\n\n\n

Y\u00f6netici \u00d6zeti<\/h3>\n\n\n\n

21.Y\u00fczy\u0131l, klinik diyagnostikte yeni bir a\u015famaya gelindi\u011fi, biyoteknolojik geli\u015fmelere dayal\u0131 molek\u00fcler diyagnostik tekni\u011finin SARS, COVID-19, Hepatit C gibi bula\u015f\u0131c\u0131 hastal\u0131klar\u0131n yan\u0131 s\u0131ra kanser gibi kronik hastal\u0131klar\u0131n da tan\u0131lan\u0131p izlenerek hastalara ki\u015fiselle\u015ftirilmi\u015f tedavi y\u00f6ntemlerinin sunuldu\u011fu bir d\u00f6nemdir.<\/p>\n\n\n\n

Molek\u00fcler diyagnostik teknolojisine dayanan testler aras\u0131nda daha sonra geli\u015ftirilen ger\u00e7ek zamanl\u0131 PCR (q PCR), geleneksel PCR\u2019\u0131n \u00f6n\u00fcne ge\u00e7erek halk sa\u011fl\u0131\u011f\u0131n\u0131 tehdit eden SARS, COVID-19 gibi vir\u00fcslerin k\u0131sa zamanda genetik haritas\u0131n\u0131n \u00e7\u0131kar\u0131lmas\u0131n\u0131 sa\u011flay\u0131p tan\u0131, tedavi ve a\u015f\u0131n\u0131n geli\u015ftirilmesini sa\u011flam\u0131\u015ft\u0131r<\/p>\n\n\n\n

Molek\u00fcler diyagnostik teknolojisini i\u00e7eren di\u011fer bir alan, PCR testleri kullan\u0131larak biyoteknolojik y\u00f6ntemlerle geneti\u011fi de\u011fi\u015ftirilmi\u015f organizmalarda (GDO) t\u00fcr tayini ve GDO tespitidir. T\u00fcr tayini veGDO qPCR testlerini de i\u00e7eren g\u0131da g\u00fcvenli\u011fi testi global Pazar b\u00fcy\u00fckl\u00fc\u011f\u00fc, 2020\u2019de 2,8 milyar dolar olup bunun 2027\u2019de 4,1 milyar dolara ula\u015fmas\u0131 beklenmektedir.<\/p>\n\n\n\n

Artan kullan\u0131m ve 2019 sonunda ortaya \u00e7\u0131kan COVID-19\u2019un da etkisiyle h\u0131zl\u0131 b\u00fcy\u00fcyen k\u00fcresel molek\u00fcler diyagnostik cihaz ve ekipmanlar\u0131 pazar\u0131, 2020\u2019de 18.074,7 milyon dolara ula\u015fm\u0131\u015ft\u0131r. 2025 ve 2030 pazar b\u00fcy\u00fcme tahminleri g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, 2025\u2019e kadar b\u00fcy\u00fcme h\u0131z\u0131n\u0131n 2020 y\u0131l\u0131na g\u00f6re d\u00fc\u015f\u00fck kalaca\u011f\u0131 ancak 2025- 2030 aras\u0131nda artaca\u011f\u0131 y\u00f6n\u00fcndedir.<\/p>\n\n\n\n

2019 y\u0131l\u0131na g\u00f6re pazar, 2020 y\u0131l\u0131nda 3 kat b\u00fcy\u00fcme kaydetmi\u015ftir. 2021 y\u0131l\u0131 ve sonras\u0131ndaki 3 y\u0131ll\u0131k tahminlerde 2020 y\u0131l\u0131na g\u00f6re bir d\u00fc\u015f\u00fc\u015f s\u00f6z konusudur ancak rakamlar hi\u00e7bir zaman 2019 y\u0131l\u0131 \u00f6ncesine inmemektedir. Bu durum g\u00f6stermektedir ki COVID-19, Pazar pay\u0131ndaki art\u0131\u015f\u0131n en \u00f6nemli sebebi olsa da tek etken de\u011fildir.<\/p>\n\n\n\n

\u00d6n\u00fcm\u00fczdeki y\u0131llarda b\u00fcy\u00fcmeyi destekleyecek di\u011fer etkenler; kanser de dahil olmak \u00fczere kronik hastal\u0131klardaki art\u0131\u015f nedeniyle molek\u00fcler te\u015fhis cihazlar\u0131na ve ekipmanlar\u0131na y\u00f6nelik artan talep, \u00e7e\u015fitli bakteriyel ve viral salg\u0131nlardaki h\u0131zl\u0131 art\u0131\u015f, artan ya\u015fl\u0131 n\u00fcfus, sa\u011fl\u0131k hizmetlerine eri\u015fimdeki art\u0131\u015f, kronik hastal\u0131klar\u0131n artan yayg\u0131nl\u0131\u011f\u0131d\u0131r. T\u00fcm bunlar\u0131n yan\u0131 s\u0131ra, \u00f6n\u00fcm\u00fczdeki y\u0131llarda COVID-19 g\u00fcn\u00fcm\u00fczdeki etkisini kaybetmi\u015f olsa da hala var olmaya devam edecek ve molek\u00fcler diyagnostik alan\u0131ndaki cihaz ve ekipmanlara duyulan ihtiya\u00e7 azalsa da devam edecektir.<\/p>\n\n\n\n

Raporda, molek\u00fcler diyagnostik pazar\u0131 \u00fcr\u00fcn tipine g\u00f6re, kullan\u0131m amac\u0131na g\u00f6re, teknolojiye g\u00f6re ve b\u00f6lgeler baz\u0131nda incelenmi\u015ftir.<\/p>\n\n\n\n

\u00dcr\u00fcn tipine g\u00f6re yap\u0131lan kitler, sarf malzemeleri, cihazlar ve yaz\u0131l\u0131m ayr\u0131m\u0131nda kitler 2020 y\u0131l\u0131ndaki 7.482,3 milyon dolarl\u0131k pay\u0131yla bu pazar\u0131n %41,4\u2019\u00fcn\u00fc domine etmektedir.<\/p>\n\n\n\n

Kullan\u0131m amac\u0131na g\u00f6re yap\u0131lan kanser, farmakogenomik, genetik testler, bula\u015f\u0131c\u0131\/infeksiy\u00f6z hastal\u0131klar, prenatal ve di\u011fer uygulamalar ayr\u0131m\u0131nda genetik testler segmenti, 7.553,6 milyon dolarl\u0131k pay\u0131yla pazar\u0131n %41,8\u2019ine sahiptir. Ancak 2020-2025 aras\u0131nda bula\u015f\u0131c\u0131 hastal\u0131klar segmentinin %1,3\u2019l\u00fck bir y\u0131ll\u0131k bile\u015fik b\u00fcy\u00fcme oran\u0131 (YBBO) ile en fazla b\u00fcy\u00fcyen sekt\u00f6r olaca\u011f\u0131 tahmin edilmektedir.<\/p>\n\n\n\n

Teknolojiye g\u00f6re yap\u0131lan DNA dizileme, PCR, \u0130zotermal N\u00fckleik Asit Amplifikasyonu, Transkripsiyon Arac\u0131l\u0131 Amplifikasyon, In Situ Melezleme, Mikro\u00e7ipler ve Di\u011fer Teknolojiler ayr\u0131m\u0131nda DNA dizileme 2020 y\u0131l\u0131ndaki 5.239,0 milyon dolarl\u0131k pazar pay\u0131 ile ilk s\u0131rada yer almaktad\u0131r. Yine ayn\u0131 y\u0131l, 5.029,5 milyon dolarl\u0131k pazar pay\u0131 ile ikinci s\u0131rada yer alan PCR ile birlikte DNA dizileme teknolojisi pazar\u0131n %50\u2019sinden fazlas\u0131n\u0131 ellerinde tutmaktad\u0131r.<\/p>\n\n\n\n

Kuzey Amerika, bu pazarda en b\u00fcy\u00fck b\u00f6lge olup (ABD ald\u0131\u011f\u0131 %42 civar\u0131ndaki payla b\u00f6lgenin en b\u00fcy\u00fc\u011f\u00fcd\u00fcr) onu Asya-Pasifik ve Bat\u0131 Avrupa izlemektedir.<\/p>\n\n\n\n

K\u00fcresel pazarda b\u00fcy\u00fck oyunculardan ilk \u00fc\u00e7\u00fc \u015funlard\u0131r: F. Hoffmann- La Roche Ltd, pazar\u0131n %19\u2019ini elinde tutarak ilk s\u0131rada yer al\u0131rken onu %5,6 ile Abbott Laboratories ve %5 ile QIAGEN NV takip etmektedir.<\/p>\n\n\n\n

T\u00fcrkiye\u2019de, molek\u00fcler diyagnostik pazar b\u00fcy\u00fckl\u00fc\u011f\u00fc 2015\u2019teki 45,5 milyon dolardan 2020\u2019de 129 milyon dolara ula\u015fm\u0131\u015f olup 2025\u2019te 166,5 milyon dolara ve 2030\u2019da 277,3 milyon dolara \u00e7\u0131kmas\u0131 \u00f6ng\u00f6r\u00fclmektedir. T\u00fcrkiye\u2019de genellikle qPCR testi kullan\u0131lmaktad\u0131r.<\/p>\n\n\n\n

T\u00fcrkiye\u2019de molek\u00fcler diyagnostik kitleri \u00fcreten birka\u00e7 firma bulunsa da Anatolia Geneworks bunlar i\u00e7erisinde a\u015fa\u011f\u0131daki \u00f6zellikleri nedeniyle \u00f6ne \u00e7\u0131kmaktad\u0131r.<\/p>\n\n\n\n

\u015eirket\u2019in uzmanl\u0131k konusu olan Real-Time PCR, DNA dizileme ve DNA\/RNA izolasyonu alan\u0131nda AR-GE ve \u00fcretimini kendi yapt\u0131\u011f\u0131, GDO konusunda kullan\u0131lanlar da dahil olmak \u00fczere, 350\u2019den fazla kiti bulunmaktad\u0131r.<\/p>\n\n\n\n

Yurti\u00e7i SARS-CoV-2 testler d\u0131\u015f\u0131ndaki molek\u00fcler diyagnostik pazar\u0131nda, Roche Holding AG, Qiagen N.V.ve Abbott Laboratories gibi global firmalar ile beraber en b\u00fcy\u00fck 4 tedarik\u00e7iden biridir. Cirosu 2019\u2019daki 21 milyon TL\u2019den 2020\u2019de 421,5 milyon TL\u2019ye y\u00fckselen firma, ayn\u0131 sat\u0131\u015flar\u0131n\u0131n %93\u2019l\u00fck bir k\u0131sm\u0131n\u0131 yurt d\u0131\u015f\u0131na yapm\u0131\u015ft\u0131r.<\/p>\n\n\n\n

Fast Company Dergisi\u2019nin ABD\u2019de ger\u00e7ekle\u015ftirilen \u201cMost Innovative Companies\u201d ara\u015ft\u0131rmas\u0131n\u0131n T\u00fcrkiye\u2019deki ilki olan \u201cEn \u0130novatif \u015eirketler\u201d \u00e7al\u0131\u015fmas\u0131nda Anatolia, Bosphore Yeni Koronavir\u00fcs Saptama Kitleri ile, T\u00fcrkiye\u2019nin En \u0130novatif 50 \u015eirketi s\u0131ralamas\u0131nda d\u00f6rd\u00fcnc\u00fc olarak ba\u015far\u0131s\u0131n\u0131 yakalam\u0131\u015ft\u0131r.<\/p>\n\n\n\n

Molek\u00fcler Diyagnostik Pazar\u0131 raporunun tamam\u0131na eri\u015fmek i\u00e7in t\u0131klay\u0131n\u0131z. <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Molek\u00fcler Diyagnostik Pazar\u0131 raporuna eri\u015fmek i\u00e7in t\u0131klay\u0131n\u0131z.  \u0130\u00e7indekiler 1. Y\u00d6NET\u0130C\u0130 \u00d6ZET\u0130  2. AMA\u00c7 ve Y\u00d6NTEM  3. G\u0130R\u0130\u015e  3.1. Molek\u00fcler Diyagnostik ve Kullan\u0131m Alanlar\u0131  4. GLOBAL MOLEK\u00dcLER D\u0130YAGNOST\u0130K PAZARI  4.1. Pazara Genel Bak\u0131\u015f  4.2. \u00dcr\u00fcn Tiplerine G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve Tahminleri  4.2.1. Kit Pazar\u0131  4.2.2. Sarf Malzemeleri Pazar\u0131  4.2.3. Cihaz Pazar\u0131  4.2.4. Yaz\u0131l\u0131m Pazar\u0131  4.3. Kullan\u0131m Amac\u0131na G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve Tahminleri  4.4. Teknolojiye G\u00f6re Pazar B\u00fcy\u00fckl\u00fckleri ve […]<\/p>\n","protected":false},"author":5,"featured_media":8540,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5182","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bizden-haberler"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/posts\/5182","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/comments?post=5182"}],"version-history":[{"count":0,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/posts\/5182\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/media\/8540"}],"wp:attachment":[{"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/media?parent=5182"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/categories?post=5182"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xsights.co.uk\/tr\/wp-json\/wp\/v2\/tags?post=5182"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}